These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16205771)

  • 1. Cancer chemoprevention: scientific promise, clinical uncertainty.
    Sporn MB; Liby KT
    Nat Clin Pract Oncol; 2005 Oct; 2(10):518-25. PubMed ID: 16205771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer chemopreventive agents-drugs for the 21st century?
    Baer-Dubowska W
    Acta Pol Pharm; 2006; 63(5):369-73. PubMed ID: 17357586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention: a primary cancer prevention strategy.
    Smith JJ; Tully P; Padberg RM
    Semin Oncol Nurs; 2005 Nov; 21(4):243-51. PubMed ID: 16293512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal metabolites modulating NF-kappaB activity: an approach to cancer therapy and chemoprevention (review).
    Petrova RD; Reznick AZ; Wasser SP; Denchev CM; Nevo E; Mahajna J
    Oncol Rep; 2008 Feb; 19(2):299-308. PubMed ID: 18202775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
    Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian timing in cancer treatment: the biological foundation for an integrative approach.
    Lis CG; Grutsch JF; Wood P; You M; Rich I; Hrushesky WJ
    Integr Cancer Ther; 2003 Jun; 2(2):105-11. PubMed ID: 15035897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities.
    Surh YJ
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():269-72. PubMed ID: 18296353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models.
    Kwon KH; Barve A; Yu S; Huang MT; Kong AN
    Acta Pharmacol Sin; 2007 Sep; 28(9):1409-21. PubMed ID: 17723174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insight in cancer treatment and prevention.
    Balducci L
    Int J Biochem Cell Biol; 2007; 39(7-8):1329-36. PubMed ID: 17531523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
    Nair S; Li W; Kong AN
    Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New frontiers in cancer treatment].
    Tortora G; Daniele G
    Recenti Prog Med; 2006 Dec; 97(12):781-6. PubMed ID: 17252737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after combined radiochemotherapy for anal cancer - retrospective analysis of efficacy, prognostic factors, and toxicity.
    Mai SK; Welzel G; Hermann B; Bohrer M; Wenz F
    Onkologie; 2008 May; 31(5):251-7. PubMed ID: 18497514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenium and colon cancer--from chemoprevention to new treatment modality.
    Rudolf E; Králová V; Cervinka M
    Anticancer Agents Med Chem; 2008 Aug; 8(6):598-602. PubMed ID: 18690824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting angiogenesis with integrative cancer therapies.
    Yance DR; Sagar SM
    Integr Cancer Ther; 2006 Mar; 5(1):9-29. PubMed ID: 16484711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention.
    Giudice A; Montella M
    Bioessays; 2006 Feb; 28(2):169-81. PubMed ID: 16435293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
    Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
    Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer.
    El-Bayoumy K; Das A; Narayanan B; Narayanan N; Fiala ES; Desai D; Rao CV; Amin S; Sinha R
    Carcinogenesis; 2006 Jul; 27(7):1369-76. PubMed ID: 16399772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
    Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW
    Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer chemoprevention: how do we know what works?
    Neugut AI; Lebwohl B; Hershman DL
    J Clin Oncol; 2007 Apr; 25(12):1461-2. PubMed ID: 17442987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.